| Literature DB >> 35568797 |
Nagarajan Muruganandam1, Rehnuma Parvez2, Avijit Roy3, Nimisha Sivanandan1, Alwin Vins1, Nisha Beniwal1, Harpreet Kaur4, Varsha Potdar5.
Abstract
BACKGROUND: Acute respiratory infections (ARIs) and severe acute respiratory illness (SARI) are public health burdens globally. The percentage of non-SARS CoV-2 respiratory viruses among patients having ARI and SARI who visit Car Nicobar's hospital settings is undocumented. Changes in the epidemiology of other respiratory viruses during COVID19 pandemic is being reported worldwide.Entities:
Keywords: Health Indigenous; Hospitalisation; Influenza; Pandemic; Respiratory tract infections; SARS CoV-2
Mesh:
Year: 2022 PMID: 35568797 PMCID: PMC9107012 DOI: 10.1186/s12879-022-07435-x
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.667
Demographic characteristics of patients with ILI in Car-Nicobar, India (2019 – 2021)
| Characteristics | All patients (N = 428, %) | Hospital settings | |
|---|---|---|---|
| Inpatient (N = 142, %) | Outpatient (N = 286, %) | ||
| Gender | |||
| Male | 212 (49.5) | 57(40.1) | 155 (54.2) |
| Female | 216 (50.5) | 85(59.9) | 131(45.8) |
| Median age years (IQR) | 35.5 (17–52) | 40.5 (6.75–59.25) | 34 (17–51)) |
| Age (Years) | |||
| 0–5 | 60 (14.4) | 34( 24.1) | 26 (9.4) |
| 6–15 | 45 (10.8) | 9 (6.4) | 36 (13.0) |
| 16–25 | 47 (11.2) | 7 (5.0) | 40 (14.4) |
| 26–35 | 62 (14.5) | 12 (8.5) | 50 (17.5) |
| 36–45 | 62 (14.5) | 20 (14.1) | 42 (14.7) |
| 46–55 | 63 (14.7) | 22 (15.7) | 41 (14.3) |
| 56–65 | 49 (11.4) | 16 (11.3) | 33 (11.5) |
| ≥ 66 | 40 (9.3) | 22 (15.5) | 18 (6.3) |
| Pre-pandemic (June 2019–July 2020) | 172 (40.1) | 53 (37.3) | 119 (41.6) |
| During pandemic (August 2020–May 2021) | 256 (59.9) | 89 (62.7) | 167 (58.4) |
Fig. 1Symptomatic distribution of Influenza-like illness in Car-Nicobar
Fig. 2Spectrum of non SARS-Cov-2 respiratory viruses in Car Nicobar
Gender and Age- wise prevalence of respiratory viruses in Car-Nicobar, India
| Respiratory viruses | Gender | Age (years) | ||||||
|---|---|---|---|---|---|---|---|---|
| Male | Female | 0–5 | 6–15 | 16–25 | 26–35 | 36–45 | 46–70 | |
| Influenza A (H1N1 pdm 09) (N = 5) | 1 | 4 | 2 | 0 | 0 | 0 | 2 | 1 |
| Influenza A (H3N2) (N = 59) | 29 | 20 | 4 | 13 | 12 | 8 | 2 | 11 |
| hMPV (N = 13) | 5 | 8 | 7 | 4 | 1 | 0 | 1 | 0 |
| RSV A (N = 2) | 2 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
| Rhinovirus (N = 11) | 10 | 1 | 1 | 1 | 3 | 2 | 0 | 3 |
| PIV—4 (N = 1) | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Adenovirus (N = 4) | 2 | 2 | 3 | 1 | 0 | 0 | 0 | 0 |
| HCoV—OC—43(N = 2) | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 0 |
| HCoV—HKU1 (N = 1) | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Total (N = 88, %) | 51 (57.9) | 37 (42.1) | 21 (23.9) | 19 (21.6) | 16 (18.2) | 11 (12.5) | 6 (6.8) | 15 (17.0) |
Fig. 3Distribution of cases during pre-pandemic (June 2019–July 2020 and pandemic August 2020–May 2021
Fig. 4Month wise distribution-o-non SARS-Cov-2 respiratory viruses